buserelin has been researched along with Hormone-Dependent Neoplasms in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (68.75) | 18.7374 |
| 1990's | 8 (25.00) | 18.2507 |
| 2000's | 2 (6.25) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fastovets, SV; Gafanov, PA; Kaprin, AD | 1 |
| Beacock, C; Buck, AC; Griffiths, K; Peeling, WB; Turkes, A; Turkes, AO; Walker, KJ; Zwink, R | 1 |
| Adenauer, H; Fazekas, AT; Klioze, S; Koutsilieris, M; Stellos, A; Tolis, G; Yakabow, A | 1 |
| Grunberg, SM | 1 |
| Chou, CY; Lee, WY; Tzeng, CC | 1 |
| Bosin, E; Hershkovitz, E; LeRoith, D; Levy, J; Marbach, M; Roberts, CT; Schally, AV; Sharoni, Y | 1 |
| Blamey, RW; Boccardo, F; Duchateau, L; Klijn, JG; Sylvester, R; Tominaga, T | 1 |
| Kennealey, GT; Vogelzang, NJ | 1 |
| Distler, W; von Matthiessen, H | 1 |
| Qayum, A; Scaletsky, R; Waxman, J | 1 |
| Diechert, U; Duda, V; Gesenhues, T; Hackenberg, R; Schulz, KD; Sturm, G | 1 |
| Griffiths, K; Turkes, AO | 1 |
| Abel, P; Cox, J; Farah, N; Fleming, J; Hewitt, G; O'Donoghue, EP; Sandow, J; Sikora, K; Waxman, J; Williams, G | 1 |
| Blamey, RW; Dyas, J; Nicholson, RI; Plowman, PN; Turkes, A; Walker, KJ; Williams, M | 1 |
| Eisenberger, MA; Friedman, MA; O'Dwyer, PJ | 1 |
| de Voogt, HJ; Geldof, AA; Rao, BR | 1 |
| Budman, DR; Delli Bovi, P; Kreis, W; Vinciguerra, V | 1 |
| Akaza, H; Isurugi, K; Kotake, T; Matsuda, M; Okajima, E; Osafune, M; Saitoh, Y; Sonoda, T; Usami, M | 1 |
| Adenis, L; Audhuy, B; Bugat, R; Colombel, P; Couette, JE; Grise, P; Khater, R; LePorz, B; Metz, R; Namer, M | 1 |
| Beacock, CJ | 1 |
| Bonichon, F; Coste, P; Lamarche, P; Mage, P; Mauriac, L; Richaud, P | 1 |
| Alcini, E; D'Addessi, A; Destito, A; Grasso, G | 1 |
| Boulton, J; Croxson, MS; Harvey, V; Holdaway, IM; Ibbertson, HK; Knox, BS | 1 |
| Denis, L; Mahler, C | 1 |
| Peeling, WB; Ryan, PG | 1 |
| Blackledge, GR; Emtage, LA; Hilton, C; Kelly, K; Trethowan, C | 1 |
| Crum, A; Handelsman, DJ; Peterson, M; Rajfer, J; Steiner, B; Swerdloff, RS | 1 |
| Klioze, SS; Miller, MF; Spiro, TP | 1 |
| Béland, G; Elhilali, M; Fradet, Y; Laroche, B; Ramsey, EW; Trachtenberg, J; Venner, PM | 1 |
| Furr, BJ; Hutchinson, FG | 1 |
6 review(s) available for buserelin and Hormone-Dependent Neoplasms
| Article | Year |
|---|---|
Role of antiprogestational therapy for meningiomas.
Topics: Buserelin; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Double-Blind Method; Estradiol; Estrogen Antagonists; Female; Glucocorticoids; Gonadal Steroid Hormones; Humans; Male; Meningeal Neoplasms; Meningioma; Menopause; Mifepristone; Neoplasms, Hormone-Dependent; Pituitary-Adrenal System; Progesterone; Randomized Controlled Trials as Topic; Thyroid Gland | 1994 |
Uterine leiomyosarcomas coexistent with cellular and atypical leiomyomata in a young woman during the treatment with luteinizing hormone-releasing hormone agonist.
Topics: Adult; Buserelin; Estrogens; Fallopian Tubes; Female; Follow-Up Studies; Humans; Hysterectomy; Leiomyomatosis; Leiomyosarcoma; Lymph Node Excision; Neoplasms, Hormone-Dependent; Neoplasms, Second Primary; Ovariectomy; Pelvis; Uterine Hemorrhage; Uterine Neoplasms | 1994 |
Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Buserelin; Drug Therapy, Combination; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Premenopause; Randomized Controlled Trials as Topic; Survival Analysis; Tamoxifen | 2001 |
Recent developments in endocrine treatment of prostate cancer.
Topics: Androgen Antagonists; Anilides; Animals; Antineoplastic Agents; Buserelin; Clinical Trials as Topic; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Neoplasms, Hormone-Dependent; Nitriles; Orchiectomy; Prostatic Neoplasms; Tosyl Compounds | 1992 |
Endocrine treatment of prostate cancer.
Topics: Androgen Antagonists; Buserelin; Clinical Trials as Topic; Diethylstilbestrol; Goserelin; Humans; Male; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms | 1989 |
Gonadotropin hormone-releasing hormone analogues: a new therapeutic approach for prostatic carcinoma.
Topics: Buserelin; Clinical Trials as Topic; Diethylstilbestrol; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Goserelin; Humans; Leuprolide; Male; Nafarelin; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms; Testosterone | 1986 |
11 trial(s) available for buserelin and Hormone-Dependent Neoplasms
| Article | Year |
|---|---|
[Somatostatin analogs in the combined treatment of patients with hormone-resistant prostate cancer].
Topics: Aged; Algorithms; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Chemotherapy, Adjuvant; Delayed-Action Preparations; Dexamethasone; Drug Administration Schedule; Drug Resistance, Neoplasm; Humans; Male; Neoplasms, Hormone-Dependent; Octreotide; Prostatic Neoplasms; Somatostatin; Treatment Outcome | 2009 |
Treatment of patients with advanced cancer of the prostate using a slow-release (depot) formulation of the LHRH agonist ICI 118630 (Zoladex).
Topics: Buserelin; Clinical Trials as Topic; Delayed-Action Preparations; Goserelin; Humans; Luteinizing Hormone; Male; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Testosterone | 1984 |
Endocrine treatment of prostate cancer.
Topics: Androgen Antagonists; Buserelin; Clinical Trials as Topic; Diethylstilbestrol; Goserelin; Humans; Male; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms | 1989 |
The clinical and endocrine assessment of three different antiandrogen regimens combined with a very long-acting gonadotrophin-releasing hormone analogue.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Cyproterone; Cyproterone Acetate; Delayed-Action Preparations; Flutamide; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Phosphoric Monoester Hydrolases; Prostatic Neoplasms; Random Allocation; Testosterone | 1988 |
Gonadotropin hormone-releasing hormone analogues: a new therapeutic approach for prostatic carcinoma.
Topics: Buserelin; Clinical Trials as Topic; Diethylstilbestrol; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Goserelin; Humans; Leuprolide; Male; Nafarelin; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms; Testosterone | 1986 |
LH-RH agonist, Zoladex (Goserelin), depot formulation in the treatment of prostatic cancer. Randomized dose-finding trial in Japan.
Topics: Aged; Aged, 80 and over; Buserelin; Delayed-Action Preparations; Follicle Stimulating Hormone; Goserelin; Humans; Injections, Subcutaneous; Japan; Luteinizing Hormone; Male; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Random Allocation; Remission Induction; Testosterone | 1988 |
Zoladex as primary therapy in advanced prostatic cancer. A French cooperative trial.
Topics: Acid Phosphatase; Aged; Aged, 80 and over; Buserelin; Delayed-Action Preparations; Follicle Stimulating Hormone; France; Goserelin; Humans; Injections, Subcutaneous; Luteinizing Hormone; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Prospective Studies; Prostate; Prostatic Neoplasms | 1988 |
U.K. trials of treatment for M1 prostatic cancer. The LH-RH analogue Zoladex vs. orchidectomy.
Topics: Aged; Buserelin; Clinical Trials as Topic; Delayed-Action Preparations; Goserelin; Humans; Injections, Subcutaneous; Male; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms; Remission Induction; Testosterone; United Kingdom | 1988 |
Interim report of a randomized trial comparing Zoladex 3.6 mg depot with diethylstilbestrol 3 mg/day in advanced prostate cancer. The West Midlands Urology Research Group.
Topics: Buserelin; Delayed-Action Preparations; Diethylstilbestrol; England; Follow-Up Studies; Goserelin; Humans; Male; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Random Allocation; Remission Induction; Testosterone | 1988 |
A randomized, comparative study of buserelin with DES/orchiectomy in the treatment of stage D2 prostatic cancer patients.
Topics: Administration, Intranasal; Administration, Oral; Buserelin; Diethylstilbestrol; Humans; Injections, Subcutaneous; Male; Multicenter Studies as Topic; Neoplasms, Hormone-Dependent; Orchiectomy; Prognosis; Prostatic Neoplasms; Random Allocation; Testosterone | 1988 |
Total androgen blockade for metastatic cancer of the prostate.
Topics: Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Combined Modality Therapy; Double-Blind Method; Humans; Imidazoles; Imidazolidines; Male; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Orchiectomy; Placebos; Prognosis; Prostatic Neoplasms; Random Allocation; Remission Induction | 1988 |
17 other study(ies) available for buserelin and Hormone-Dependent Neoplasms
| Article | Year |
|---|---|
Metastatic prostate cancer: hormone dependency and therapeutic efficacy of GnRH analogues.
Topics: Buserelin; Castration; Combined Modality Therapy; Humans; Male; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Prostatic Neoplasms | 1984 |
Luteinizing hormone-releasing hormone antagonists interfere with autocrine and paracrine growth stimulation of MCF-7 mammary cancer cells by insulin-like growth factors.
Topics: Analysis of Variance; Breast Neoplasms; Buserelin; Cell Division; Dose-Response Relationship, Drug; Estradiol; Gonadotropin-Releasing Hormone; Humans; Insulin; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Neoplasms, Hormone-Dependent; Radioimmunoassay; Time Factors; Tumor Cells, Cultured | 1993 |
Goserelin--another LH-RH analog for prostate cancer.
Topics: Buserelin; Drug Implants; Goserelin; Humans; Male; Neoplasms, Hormone-Dependent; Palliative Care; Prostatic Neoplasms | 1990 |
[Report of the International Symposium on "Zoladex--the new therapy concept in breast cancer" Cambridge, 9-11 September 1990].
Topics: Breast Neoplasms; Buserelin; Combined Modality Therapy; Female; Goserelin; Humans; Neoplasms, Hormone-Dependent | 1991 |
Endocrine and clinical aspects of new compounds for treatment of hormone-related cancer in gynecology.
Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Neoplasms, Hormone-Dependent; Tamoxifen | 1990 |
Autocrine stimulation by gonadotrophin-releasing hormone-like factors of human hormone-responsive prostate cancer cells in culture.
Topics: Buserelin; Cell Division; Gonadotropin-Releasing Hormone; Humans; Male; Neoplasms, Hormone-Dependent; Peptide Hydrolases; Prostatic Neoplasms; Radioimmunoassay; Receptors, LHRH; Tumor Cells, Cultured | 1990 |
[New possibilities for differentiated therapy of leiomyoma of the uterus using the GnRH agonist zoladex].
Topics: Adult; Buserelin; Delayed-Action Preparations; Female; Goserelin; Humans; Injections, Subcutaneous; Leiomyoma; Neoplasms, Hormone-Dependent; Ultrasonography; Uterine Neoplasms; Uterus | 1989 |
Endocrinological and clinical aspects of LHRH action (ICI 118630) in hormone dependent breast cancer.
Topics: Adult; Breast Neoplasms; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Menopause; Middle Aged; Neoplasms, Hormone-Dependent; Ovary; Pituitary Gland; Progesterone; Receptors, Estrogen; Time Factors | 1985 |
Renewal timing of long-acting depot luteinizing hormone-releasing hormone agonist (Zoladex) is critical in the treatment of hormone-dependent rat prostatic carcinoma (R3327-H).
Topics: Androgens; Animals; Buserelin; Delayed-Action Preparations; Gonadotropin-Releasing Hormone; Goserelin; Kidney; Male; Neoplasms, Hormone-Dependent; Organ Size; Prostate; Prostatic Neoplasms; Rats; Seminal Vesicles; Testis; Testosterone | 1987 |
Rapid rise of serum testosterone following discontinuation of long term treatment of prostate carcinoma with an LHRH-agonist.
Topics: Buserelin; Drug Evaluation; Goserelin; Humans; Male; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Substance Withdrawal Syndrome; Testosterone | 1988 |
Long-term results of treating advanced prostatic cancer with the LH-RH analogue Zoladex.
Topics: Buserelin; Follow-Up Studies; Goserelin; Humans; Male; Neoplasms, Hormone-Dependent; Pain; Prognosis; Prostatic Neoplasms; Testosterone; Time Factors | 1988 |
Clinical study of an LH-RH agonist (ICI 118.630, Zoladex) in the treatment of prostatic cancer.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Buserelin; Carcinoma; Delayed-Action Preparations; Goserelin; Humans; Injections, Subcutaneous; Male; Middle Aged; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Remission Induction | 1988 |
LH-RH analogue treatment for advanced prostate cancer.
Topics: Aged; Aged, 80 and over; Buserelin; Delayed-Action Preparations; Follow-Up Studies; Goserelin; Humans; Injections, Subcutaneous; Luteinizing Hormone; Male; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Remission Induction; Testosterone | 1988 |
Zoladex treatment of symptomatic prostatic carcinoma.
Topics: Buserelin; Carcinoma; Delayed-Action Preparations; Goserelin; Humans; Injections, Subcutaneous; Male; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Remission Induction; Testosterone | 1988 |
Simultaneous administration of a luteinizing hormone releasing hormone agonist and diethylstilbestrol in the initial treatment of prostatic cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Delayed-Action Preparations; Diethylstilbestrol; Follicle Stimulating Hormone; Goserelin; Humans; Injections, Subcutaneous; Luteinizing Hormone; Male; Middle Aged; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Testosterone | 1988 |
Comparison of the efficacy of subcutaneous and nasal spray buserelin treatment in suppression of testicular steroidogenesis in men with prostate cancer.
Topics: Administration, Intranasal; Aged; Buserelin; Dihydrotestosterone; Drug Evaluation; Estradiol; Gonadal Steroid Hormones; Humans; Injections, Subcutaneous; Luteinizing Hormone; Male; Middle Aged; Neoplasms, Hormone-Dependent; Prospective Studies; Prostatic Neoplasms; Random Allocation; Testis; Testosterone | 1986 |
Biodegradable sustained release formulation of the LH-RH analogue 'Zoladex' for the treatment of hormone-responsive tumours.
Topics: Animals; Buserelin; Delayed-Action Preparations; Female; Goserelin; Male; Mammary Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Rats | 1985 |